Birgitta Versluijs

154 Supplemental data FIGURE S1. Cumulative incidences of therapy failure according to ICU admission for mechanical ventilation (a) and GVHD treatment prior to Allo-LS (b). FIGURE S2. Cumulative inncidence of non relapse mortality (NRM) according to presence of respiratory viruses (a) and ICU admission for mechanical ventilation (b). —  No ICU admission —  ICU admission —  No GvHD treatment —  GvHD treatment —  No RV present —  RV present —  No ICU admission —  ICU admission 8 A B A B 55% (28-72%) 37% (17-52%) p=0.015* 22 31 21 18 8 6 Therapy failure (%) 100 75 50 25 0 100 75 50 25 0 Time after Allo-LS onset (days) 0 200 400 Number at risk 100% (N/A) 37% (21-49%) p=0.002** 47 6 1 0 28 24 Time after Allo-LS onset (days) 0 200 Number at risk 400 NRM incidence (%) 100 75 50 25 0 20 23 17 16 6 4 Time after Allo-LS onset (days) 0 300 Number at risk 600 15 4 900 p=0.002** 75% ± 20% 26% ± 18% 100 75 50 25 0 p=0.003** 33% ± 17% 68% ± 20% 31 22 8 7 23 19 Time after Allo-LS onset (days) 0 300 Number at risk 600 7 16 900